Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-13 22:15:16 EDT

Explore

PostsPeople
LatestRanked
Load more
@royalfreecharity.orgSep 15, 2026, 2:50 PM

🦠 Could gut bacteria reveal who is at risk of Parkinson’s disease?

Research supported has identified distinct microbiome changes linked to Parkinson’s, before symptoms appear.

Read the full story in our latest Further, Faster, For All magazine: 📖 issuu.com/royalfreecha...

#Parkinsons #Research

@magnesnushu.bsky.socialSep 15, 2026, 2:05 PM

Become a NUSHU Partner! 👟 Real-world gait monitoring, 📱 vibrotactile feedback, 📊 clinician insights, 🏠 support beyond clinic. #NUSHU #Parkinsons #Neurorehabilitation #DigitalHealth #MedTech #Mobility #ClinicalInnovation #WearableTechnology

Photo, no description
@asapresearch.parkinsonsroadmap.orgSep 15, 2026, 1:43 PM

What changes when researchers can build on one another’s work earlier? 🔓

For #OpenScienceWeek, Hina Ojha, PhD, of CRN Team Muqit shares how early access and cross-lab collaboration can spark new directions and strengthen #Parkinsons research ⬇️

#ScienceForAll 🧪

Hina Ojha, PhD, of the University of Dundee, Scotland, and CRN Team Muqit. Her headshot appears on the right against a dark blue, green, and purple network-pattern background with the ASAP logo.Open Science Week quote graphic with a light, abstract network-pattern background and purple accents. A large purple “01” appears on the left, with the question at the top: “How has open science helped you share your work and access, reuse, or build upon research from others?” Below a thin purple divider, Hina Ojha, PhD, responds: “Open science gives access to work that might otherwise stay hidden for months through peer review, publication delays, or negative results. Platforms like bioRxiv let us see, question, and build on findings earlier. In disease research, where every moment counts, that early access can spark an important new direction.”Open Science Week quote graphic with a dark navy and purple abstract network-pattern background. A large purple “02” appears on the left, with the question in white at the top: “How can open science help move Parkinson’s discoveries closer to better treatments, care, or everyday outcomes?” Below a thin purple divider, Hina Ojha, PhD, responds: “For a long time, science rewarded labs for competing and protecting their work, and sometimes we lost sight of why we entered the field: to understand disease and help patients. Initiatives like ASAP have pushed us to collaborate and opened many eyes to how much faster and better science can move when we work with, rather than against, each other.”Open Science Week quote graphic with a light, abstract network-pattern background and purple accents. A large purple “03” appears on the left, with the question at the top: “How has access to another researcher’s data, methods, tools, or resources influenced the direction of your own work?” Below a thin purple divider, Hina Ojha, PhD, responds: “Collaboration taught me that you do not need the burden of knowing everything. In some projects, another lab brought the biology while I contributed structural insight. Each of us brought what we did best, and together the work became something neither could have achieved alone.”
@dustcircle.bsky.socialSep 15, 2026, 1:03 PM

#Emmys 2026:
#MichaelJFox Makes Emotional #Speech as He Accepts #BobHopeHumanitarianAward

www.youtube.com/watch?v=9Pfr...

The #actor/ #philanthropist, who has raised over $1 billion for #Parkinsons research through his foundation, was honored by his 'The Good Wife' co-star, #JuliannaMargulies.

@montelwilliams.bsky.socialSep 15, 2026, 11:51 AM

NEWS
You Might Have Missed

@parkinsonseurope.bsky.social
@parkinsonssucks.bsky.social
@parkinsonsway.bsky.social
#parkinsons #health #wellness #education #mmj #mmjpatient #mmjcommunity #usa #care

Photo, no description
@socialnews.xyzSep 15, 2026, 3:51 AM

Michael J. Fox: Initially, I kept my Parkinson's diagnosis a secret #MichaelJFoxInitiallyI #Parkinsons #socialnewsxyz

@scienceofpd.bsky.socialSep 14, 2026, 6:46 PM

New review explores vit D research in neurodegen. condition, including #Parkinsons; "Currently, there is a limited number of high-quality, large-scale clinical trials investigating the impact of vit D on specific mental health or neurological outcomes"
www.cell.com/heliyon/full...

Photo, no descriptionPhoto, no descriptionPhoto, no description
@ubuffalo.bsky.socialSep 14, 2026, 3:20 PM

Brain gains 🧠 #UBuffalo to lead a new statewide SUNY Brain Institute network, accelerating research on #Alzheimers, #Parkinsons and other age-related neurological disorders. 🔽

@sunyofficial.bsky.social

@biosapiens.bsky.socialSep 14, 2026, 1:34 AM

Demmings et al. (2026) revealed that sustained stress activates ATF4, suppressing mTOR and driving neuron death in Parkinson's models. Check out the video.
youtu.be/L0QBsKOhKMI
#Neuroscience #Parkinsons

@scienceofpd.bsky.socialSep 13, 2026, 9:52 PM

New study finds no significant or consistent association between levodopa exposure & freezing of gait severity or incidence after adjustment for disease duration & severity in 25K people with #Parkinsons (across 2 cohorts: PPMI & NSPARK)
www.neurology.org/doi/10.1212/...

@scienceofpd.bsky.socialSep 13, 2026, 9:48 PM

New review article provides consensus expert recommendations for management of urinary dysfunction in #Parkinsons, with a useful initial evaluation & treatment chart
www.prd-journal.com/article/S135...

Photo, no description
@scienceofpd.bsky.socialSep 13, 2026, 9:46 PM

Say it with me: "Sparky samba"!

The protocol for the Sparky samba study has been published. This is a multi-centre randomised controlled feasibility trial with embedded process evaluation of a samba percussion intervention for 60 people with #Parkinsons
bmjopen.bmj.com/content/16/9...

Photo, no description
@worldpdcongress.bsky.socialSep 13, 2026, 9:41 PM

Three #YOPD advocates. Three global voices. One powerful force for change. 💜🌎 #WPC2026 #Parkinsons

Photo, no description
@scienceofpd.bsky.socialSep 12, 2026, 11:24 AM

Researchers from Lysoway Therapeutics & collaborators present preclinical data on their brain-penetrant TRPML1 agonist, LW-1017, which enhances autophagy–lysosomal function & mitigates pathology in aged models of #Parkinsons & #Alzheimers - one to watch!
www.nature.com/articles/s41...

Photo, no descriptionPhoto, no descriptionPhoto, no descriptionPhoto, no description
@neurologyacademy.bsky.socialSep 11, 2026, 2:41 PM

A few last-minute spaces are still available for our #Parkinsons Foundation MasterClass in less than 3 weeks!

🗓️ Dates: 29th - 30th September 2026
📍 Location: Halifax Hall, Sheffield University Campus / virtual attendance

Register now:
neurologyacademy.org/events/cours...

Photo, no description
@scienceofpd.bsky.socialSep 11, 2026, 12:22 PM

New research finds administration of the fatty acid nitroalkene 10-nitro-octadec-9-enoic acid (10-NO2-OA) in a chronic rotenone rat model of #Parkinsons induced biochemical responses that reduced neuronal damage, nigrostriatal degen. & motor impairment
www.nature.com/articles/s41...

Photo, no descriptionPhoto, no descriptionPhoto, no description
@scienceofpd.bsky.socialSep 10, 2026, 7:00 PM

New clinical trial registered: The Vista PD study is a 12 week randomized, placebo-controlled, multicenter study to evaluate the efficacy, PK, safety, & tolerability of VIM0423 (muscarinic cholinergic receptor antagonist) in 80 people with #Parkinsons
clinicaltrials.gov/study/NCT078...

@scienceofpd.bsky.socialSep 10, 2026, 6:56 PM

New clinical trial registered: The ARREST-PD study is a 72-week multicenter, randomized, double-blind, placebo-controlled Phase 2 trial evaluating the disease-modifying efficacy of Sitagliptin therapy in 160 people with early-stage #Parkinsons
clinicaltrials.gov/study/NCT078...

@scienceofpd.bsky.socialSep 10, 2026, 6:07 PM

Over the 50-day study, PK analysis showed brain penetrance & dose-dependent exposure; Results support weekly dosing; Clear trends seen for biomarker movement; Majority of #Parkinsons patients who received TT-P34 showed a coordinated response across lysosomal proteins in CSF